Report of Foreign Issuer (6-k)
31 May 2019 - 8:37PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
May 2019
Commission File Number:
0001723069
Tiziana Life Sciences plc
(Exact Name of Registrant as Specified in Its
Charter)
3
rd
Floor,
11-12 St James’s Square
London SW1Y 4LB
United Kingdom
(Address of registrant’s principal executive
office)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On May 31, 2019, Tiziana Life Sciences plc
(the “
Company
”) held its Annual General Meeting of shareholders (“
AGM
”).
The Regulatory News Service announcement confirming
the results of the AGM (the “
AGM Results RNS Announcement
”) is furnished herewith as Exhibit 99.1 to this Report
on Form 6-K.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
TIZIANA LIFE SCIENCES PLC
|
|
|
|
|
|
|
|
|
Date: May 31, 2019
|
By:
|
/s/ Kunwar Shailubhai
|
|
|
Name:
|
Kunwar Shailubhai
|
|
|
Title:
|
Chief Executive Officer
|
2
EXHIBIT INDEX
Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Jul 2023 to Jul 2024